Evaluation of Dose Distribution of Molecular Delivery After Blood-Brain Barrier Disruption by Focused Ultrasound with Treatment Planning

Ultrasound in Medicine and Biology

Volumn 39, Issue 4, 2013, Pages 620-627

  Yang, Feng Yi ^a   Chen, Chien Cheng ^b   Kao, Yi Hsuan ^a   Chen, Chuan Lin ^a   Ko, Chia En ^a   Horng, Shih Cheng ^c   Chen, Ran Chou ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Blood brain barrier disruption; Dose distribution; Focused ultrasound; Multiple sonications; Treatment planning

Indexed keywords

BLOOD; MAGNETIC RESONANCE IMAGING; ULTRASONICS;

BLOOD-BRAIN BARRIER; DOSE DISTRIBUTIONS; FOCUSED ULTRASOUND; REPETITION FREQUENCY; SIGNIFICANT DIFFERENCES; TREATMENT PLANNING; ULTRASOUND CONTRAST AGENT; ULTRASOUND FREQUENCY;

SONICATION;

ECHO CONTRAST MEDIUM; EVANS BLUE; GADOLINIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ERYTHROCYTE; FOCUSED ULTRASOUND; HISTOLOGY; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RAT; TREATMENT PLANNING; ULTRASOUND;

EID: 84875103421     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2012.11.027     Document Type: Article

References (23)

1. Allen T.M., Cullis P.R. Drug delivery systems: Entering the mainstream. Science 2004, 303:1818-1822.
2. Choi J.J., Pernot M., Brown T.R., Small S.A., Konofagou E.E. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 2007, 52:5509-5530.
3. Fennessy F.M., Tempany C.M., McDannold N.J., So M.J., Hesley G., Gostout B., Kim H.S., Holland G.A., Sarti D.A., Hynynen K., Jolesz F.A., Stewart E.A. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology 2007, 243:885-893.
4. Floyd J.D., Nguyen D.T., Lobins R.L., Bashir Q., Doll D.C., Perry M.C. Cardiotoxicity of cancer therapy. J Clin Oncol 2005, 23:7685-7696.
5. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 2008, 60:1209-1217.
6. Hynynen K., McDannold N., Sheikov N.A., Jolesz F.A., Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005, 24:12-20.
7. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001, 220:640-646.
8. McDannold N., Vykhodtseva N., Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol 2008, 34:930-937.
9. Pardridge W.M. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2005, 2:3-14.
10. Park J.W., Hong K., Kirpotin D.B., Colbern G., Shalaby R., Baselga J., Shao Y., Nielsen U.B., Marks J.D., Moore D., Papahadjopoulos D., Benz C.C. Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery. Clin Cancer Res 2002, 8:1172-1181.
11. Ponce A.M., Viglianti B.L., Yu D., Yarmolenko P.S., Michelich C.R., Woo J., Bally M.B., Dewhirst M.W. Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst 2007, 99:53-63.
12. Rogawski M.A. Convection-enhanced delivery in the treatment of epilepsy. Neurotherapeutics 2009, 6:344-351.
13. Tempany C.M., Stewart E.A., McDannold N., Quade B.J., Jolesz F.A., Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: A feasibility study. Radiology 2003, 226:897-905.
14. Uyama O., Okamura N., Yanase M., Narita M., Kawabata K., Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 1988, 8:282-284.
15. Yang F.Y., Horng S.C., Lin Y.S., Kao Y.H. Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J Magn Reson Imaging 2010, 32:593-599.
16. Yang F.Y., Lee P.Y. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound. Int J Nanomedicine 2012, 7:2573-2582.
17. Yang F.Y., Lin G.L., Horng S.C., Chang T.K., Wu S.Y., Wong T.T., Wang H.E. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model. IEEE Trans Ultrason Ferroelectr Freq Control 2011, 58:964-970.
18. Yang F.Y., Lin Y.S., Kang K.H., Chao T.K. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J Control Release 2011, 150:111-116.
19. Yang F.Y., Liu S.H., Ho F.M., Chang C.H. Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption. J Acoust Soc Am 2009, 126:3344-3349.
20. Yang F.Y., Teng M.C., Lu M., Liang H.F., Lee Y.R., Yen C.C., Liang M.L., Wong T.T. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int J Nanomedicine 2012, 7:965-974.
21. Yang F.Y., Wang H.E., Lin G.L., Lin H.H., Wong T.T. Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound. Int J Nanomedicine 2012, 7:723-730.
22. Yang F.Y., Wang H.E., Lin G.L., Teng M.C., Lin H.H., Wong T.T., Liu R.S. Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J Nucl Med 2011, 52:478-484.
23. Yang F.Y., Wong T.T., Teng M.C., Liu R.S., Lu M., Liang H.F., Wei M.C. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release 2012, 160:652-658.